Breast Cancer and Copper Deficiency

Understanding the Biology of Breast Cancer and How Copper Deficiency Improves Survival Rates 

In addition to supporting groundbreaking MPN research opportunities, CR&T funded several critical breast cancer initiatives. This included studies aimed at achieving a greater understanding of the basic biology of breast cancer, recurrence rates in various types of breast cancer and common side effects.

One particularly innovative trial funded by CR&T, known as “The Effect of Tetriathiomolybdate on Circulating Endothelial Progenitor Cells in Patients with Breast Cancer at High Risk of Recurrence,” discovered that individuals could reduce the risk of cancer recurrence by lowering copper levels in their diets and bodies.

Led by Dr. Linda Vahdat, a well-respected member of the CR&T Medical Advisory Board and Director at the Weill Cornell Breast Cancer Center, the trial found that copper deficiencies may prevent the spread of breast cancer cells and the formation of blood vessels, a process that researchers believe is central in breast cancer recurrence. These exciting results were presented at the world’s premier breast cancer conference in San Antonio and have major implications for limiting breast cancer recurrence in high-risk patients. 

Read an article about the Phase 2 clinical study of this treatment>>

Learn how you can help advance the next phase of this research through crowdfunding>>